According to Omeros Corporation's latest financial reports the company's current EPS (TTM) is $0.64. In 2022 the company made an earnings per share (EPS) of $0.75 a decrease over its 2021 EPS that were of $3.09.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $0.64 | -14.67% |
2022 | $0.75 | -75.73% |
2021 | $3.09 | -228.75% |
2020 | -$2.40 | 41.18% |
2019 | -$1.70 | -34.87% |
2018 | -$2.61 | 123.08% |
2017 | -$1.17 | -29.09% |
2016 | -$1.65 | -17.5% |
2015 | -$2.00 | -9.91% |
2014 | -$2.22 | 62.04% |
2013 | -$1.37 | -13.84% |
2012 | -$1.59 | 23.26% |
2011 | -$1.29 | -5.15% |
2010 | -$1.36 | -75.55% |
2009 | -$5.56 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $14.09 | 2,100.83% | ๐บ๐ธ USA |
Pfizer PFE | $1.86 | 190.63% | ๐บ๐ธ USA |
Genetic Technologies GENE | N/A | N/A | ๐ฆ๐บ Australia |
Eterna Therapeutics ERNA | -$5.64 | -981.25% | ๐บ๐ธ USA |